Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 21, 2014
Pseudoazurin from Sinorhizobium meliloti as an electron donor to copper-containing nitrite reductase: influence of the redox partner on the reduction potentials of the enzyme copper centersFélix M Ferroni, Jacopo Marangon, Nicolás I Neuman, et al.
Conservation Physiology|May 2, 2022
Survival estimates across five life stages of redfin (Perca fluviatilis) exposed to simulated pumped-storage hydropower stressorsKatherine E Doyle, Nathan Ning, Luiz G M Silva, et al.
The American Journal of Cardiology|November 15, 2000
Effect of aspirin and ticlopidine on plasma tissue factor levels in stable and unstable angina pectorisJ Marco, R A Ariëns, J Fajadet, et al.
JAMA|May 30, 1998
Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjectsI I Wistuba, C Behrens, S Milchgrub, et al.
European Review for Medical and Pharmacological Sciences|December 19, 2023
Unraveling the complexity of anti-doping analysis: reassessing meldonium detection and doping verdicts in a case studyS Cristoni, F Vitarelli, S Spiti, et al.
Computational and Mathematical Methods in Medicine|June 17, 2015
An Adaptive Thresholding Method for BTV Estimation Incorporating PET Reconstruction Parameters: A Multicenter Study of the Robustness and the ReliabilityM Brambilla, R Matheoud, C Basile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete ResectionMing-Sound Tsao, Sophie Marguet, Gwénaël Le Teuff, et al.
ESMO Open|December 1, 2022
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkersG Lo Russo, F Sgambelluri, A Prelaj, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health recordsL Mazzeo, F Corso, P Baili, et al.
ESMO Open|June 15, 2024
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)E G Pizzutilo, A G Agostara, S Oresti, et al.
Pageof 14